Laurion Capital Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Laurion Capital Management’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-412,865	Closed	-$111K	–	734
2023 Q2	$111K	Sell	412,865 -18,535	-4%	-$10.5K	﹤0.01%	514
2023 Q1	$242K	Hold	431,400	–	–	﹤0.01%	376
2022 Q4	$319K	Hold	431,400	–	–	﹤0.01%	369
2022 Q3	$984K	Hold	431,400	–	–	0.01%	371
2022 Q2	$1.37M	Buy	+431,400	New	+$1.55M	0.02%	258

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Laurion Capital Management's SQZ Position: Q3 2023 in Review

Laurion Capital Management sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 412,865 shares — an estimated $111K sold.

Laurion Capital Management first reported a position in SQZ in Q2 2022 and held it in 5 quarters. The position peaked at $1.37M in Q2 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

Laurion Capital Management reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
Laurion Capital Management sold 412,865 SQZ Biotechnologies Company shares in Q3 2023, an estimated $111K.
Laurion Capital Management first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 5 quarters.
Laurion Capital Management's SQZ Biotechnologies Company position peaked at $1.37M in Q2 2022.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.